Published Date: 08 Mar 2023
Interventions to improve clinical practice increased the odds that people with type 2 diabetes and heart disease were prescribed the drugs recommended in our study by more than 100%.
Read Full NewsAbout one third of cancers detected by PSA screening at age 70, and more than half at age 80, are unlikely to become clinically meaningful within 15 years.
A ‘target trial’ emulation study suggests that regular exercise can help breast cancer survivors live longer.
Broader implementation would require substantial investment, but long-term dividends of liquid biopsy analysis in the region could affect diagnosis and care of much more than just this cancer.
Counterintuitive findings hint that diets rich in fruit, vegetables, and whole grains may increase the risk of lung cancer in young nonsmokers, but experts are skeptical.
Photopenia in high CT density renal lesions on [18F]FDG PET/CT scans shows a high negative predictive value for excluding malignancy.
A phase 2 study investigates the combination of cladribine plus low-dose cytarabine and venetoclax alternating with azacitidine plus venetoclax for newly diagnosed acute myeloid leukemia.
Approval was based on findings from the phase 3 VERITAC-2 trial showing significantly improved PFS for patients with ESR1-mutated disease.
1.
Discovery of a new biomarker for early detection of bladder cancer in both dogs and humans
2.
One-third of childhood cancer survivors experience significant fear that it could come back, study reveals
3.
Study finds 10% of pediatric blood cancers may stem from medical imaging radiation
4.
Prostate cancer therapies: AI-based image analysis detects early organ damage
5.
Despite reports of hundreds of cancer cases, carcinogens have been discovered at nuclear missile sites in Montana.
1.
New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results
2.
Machine Learning in Genomic Analysis for Early Lung Cancer Detection: Key Advances and Insights
3.
Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon
4.
Understanding Melanoma: From Diagnosis to Healing and Excision in Denver
5.
The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
3.
Navigating the Complexities of Ph Negative ALL - Part I
4.
Navigating the Complexities of Ph Negative ALL - Part III
5.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation